J&J restoring cancer drug supply to EU patients - CBS News

J&J restoring cancer drug supply to EU patients - CBS News

J&J restoring cancer drug supply to EU patients

• Comment
  /
• Shares /
• 1 Tweets /
• Stumble /
• Email
• More +

TRENTON, N.J. — Johnson & Johnson is making more headway in restoring supplies of a crucial cancer drug unavailable to many patients since the contract manufacturer producing it, Ben Venue Laboratories, shut down a year ago due to serious contamination and other quality problems at its Ohio factory.

Access to Doxil, or Caelyx as it's called in the European Union and some other places, had been limited to existing patients since last fall amid dwindling supply. The drug treats advanced breast and ovarian cancers, the bone marrow cancer multiple myeloma and Kaposi's sarcoma, a blood vessel cancer. For many patients, it was the only effective option......